Qiagen NV Stock price Xetra
Equities
NL0000240000
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | 0.00% |
Sales 2024 * | 2.01B 1.87B | Sales 2025 * | 2.16B 2B | Capitalization | 9.52B 8.82B |
---|---|---|---|---|---|
Net income 2024 * | 397M 368M | Net income 2025 * | 446M 413M | EV / Sales 2024 * | 4.88 x |
Net Debt 2024 * | 303M 280M | Net cash position 2025 * | 281M 260M | EV / Sales 2025 * | 4.29 x |
P/E ratio 2024 * |
24.2
x | P/E ratio 2025 * |
21.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.45% |
Latest transcript on Qiagen NV
Managers | Title | Age | Since |
---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 15-01-31 |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Roland Sackers
DFI | Director of Finance/CFO | 56 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 11-05-31 | |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Lawrence Rosen
CHM | Chairman | 66 | 13-06-25 |
1st Jan change | Capi. | |
---|---|---|
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |
- Stock
- Equities
- Stock Qiagen N.V.
- Stock Qiagen NV - Xetra